Infinity Pharmaceuticals Valuation
| INFIQ Stock | 0.0001 0.00 0.00% |
Infinity Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Infinity Pharmaceuticals from evaluating the firm fundamentals such as Return On Asset of -0.61, shares owned by insiders of 2.68 %, and Operating Margin of (17.36) % as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Infinity Pharmaceuticals' valuation include:
Price Book 8.0285 | Enterprise Value -17.1 M | Enterprise Value Ebitda 0.5882 | Price Sales 0.0035 |
Overvalued
Today
Please note that Infinity Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Infinity Pharmaceuticals is based on 3 months time horizon. Increasing Infinity Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Infinity Pharmaceuticals' intrinsic value may or may not be the same as its current market price of 0.0001, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Infinity Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Infinity Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Infinity Pharmaceuticals helps investors to forecast how Infinity stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Infinity Pharmaceuticals more accurately as focusing exclusively on Infinity Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Infinity Pharmaceuticals' intrinsic value based on its ongoing forecasts of Infinity Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Infinity Pharmaceuticals' closest peers.
Infinity Pharmaceuticals Cash |
|
Infinity Valuation Trend
Infinity Pharmaceuticals' real value is important for investors to make better decisions and a more accurate overall view of Infinity Pharmaceuticals' financial worth over time. Using both Infinity Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Infinity Pharmaceuticals Total Value Analysis
Infinity Pharmaceuticals is currently forecasted to have takeover price of (17.1 M) with market capitalization of 9.08 K, debt of 917 K, and cash on hands of . The negative valuation of Infinity Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Infinity Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(17.1 M) | 9.08 K | 917 K |
Infinity Pharmaceuticals Investor Information
The company recorded a loss per share of 0.46. Infinity Pharmaceuticals had not issued any dividends in recent years. The entity had 1:4 split on the 13th of September 2006. Based on the key indicators related to Infinity Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Infinity Pharmaceuticals may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Infinity Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Infinity Pharmaceuticals has an asset utilization ratio of 6.15 percent. This connotes that the Company is making USD0.0615 for each dollar of assets. An increasing asset utilization means that Infinity Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Infinity Pharmaceuticals Ownership Allocation
Infinity Pharmaceuticals has a total of 90.76 Million outstanding shares. Roughly 97.32 (percent) of Infinity Pharmaceuticals outstanding shares are held by general public with 2.68 % owned by insiders and only 0.0 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Infinity Pharmaceuticals Profitability Analysis
The company reported the revenue of 2.59 M. Net Loss for the year was (44.37 M) with loss before overhead, payroll, taxes, and interest of (31.38 M).About Infinity Pharmaceuticals Valuation
The stock valuation mechanism determines Infinity Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Infinity Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Infinity Pharmaceuticals. We calculate exposure to Infinity Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Infinity Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.2 M | 1.2 M | |
| Pretax Profit Margin | (19.68) | (20.66) | |
| Operating Profit Margin | (19.89) | (20.88) | |
| Net Loss | (19.68) | (20.66) | |
| Gross Profit Margin | 0.36 | 0.38 |
Infinity Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Infinity Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 89.2 M |
Infinity Pharmaceuticals Current Valuation Indicators
Infinity Pharmaceuticals' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Infinity Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Infinity Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Infinity Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Infinity Pharmaceuticals' worth.Additional Tools for Infinity Stock Analysis
When running Infinity Pharmaceuticals' price analysis, check to measure Infinity Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuticals is operating at the current time. Most of Infinity Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infinity Pharmaceuticals' price. Additionally, you may evaluate how the addition of Infinity Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.